El-Tamalawy_2022_Front.Pharmacol_13_855764

Reference

Title : Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial - El-Tamalawy_2022_Front.Pharmacol_13_855764
Author(s) : El-Tamalawy MM , Soliman MM , Omara AF , Rashad A , Ibrahim OM , El-Shishtawy MM
Ref : Front Pharmacol , 13 :855764 , 2022
Abstract : El-Tamalawy_2022_Front.Pharmacol_13_855764
ESTHER : El-Tamalawy_2022_Front.Pharmacol_13_855764
PubMedSearch : El-Tamalawy_2022_Front.Pharmacol_13_855764
PubMedID: 35330830

Related information

Citations formats

El-Tamalawy MM, Soliman MM, Omara AF, Rashad A, Ibrahim OM, El-Shishtawy MM (2022)
Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial
Front Pharmacol 13 :855764

El-Tamalawy MM, Soliman MM, Omara AF, Rashad A, Ibrahim OM, El-Shishtawy MM (2022)
Front Pharmacol 13 :855764